Get Tickets Donate

Denmark

Launching in 2023, Nucleate Denmark and the Activator Program have been warmly welcomed to the Danish biotech ecosystem with a great amount of support.

Follow Nucleate Denmark

Become a mentor

REGIONAL LEADERSHIP

Carlotta Strelow

Carlotta Strelow
Co-Managing Director
Christoffer Merrild
Co-Managing Director
Justus Florian Gräf
Director of Operations
Venla Väänänen
Director of Communications
Christoffer Rode
Operations Lead
Emil Funk Vangsgaard
Operations Lead
Julia Montoliu
Communications Lead
Sofus Bergholt
Operations Lead
Miguel Puga Sánchez
Communications Lead
Kasper Budolph Pedersen
Advisor
Petar Todorov
Advisor
Victor Svenstrup
Advisor
Jonas Arnold Jürgensen
Advisor

<br /> — Carlotta Strelow
Co-Managing Director

<br /> — Christoffer Merrild
Co-Managing Director

<br /> — Justus Florian Gräf
Director of Operations

<br /> — Venla Väänänen
Director of Communications

<br /> — Christoffer Rode
Operations Lead

<br /> — Emil Funk Vangsgaard
Operations Lead

<br /> — Julia Montoliu
Communications Lead

<br /> — Sofus Bergholt
Operations Lead

<br /> — Miguel Puga Sánchez
Communications Lead

<br /> — Kasper Budolph Pedersen
Advisor

<br /> — Petar Todorov
Advisor

<br /> — Victor Svenstrup
Advisor

<br /> — Jonas Arnold Jürgensen
Advisor

If you’re ready to build your bioventure, let’s get in touch.

Apply for
Activator

2024 COHORT

Nucleate's Activator forms pioneering biotech companies without taking equity.
Timeline and FAQ.

Deadline for US chapters is October 21st. Deadline for international chapters will vary. Please contact your local chapter to verify.

REQUIREMENTS

01

Approval from PI
02

Well defined technology / product backed by preliminary scientific research (Therapeutic modalities - Platform technologies - Diagnostics - Medical Devices)
03

Existing IP to protect the technology, or clear path to file IP within the next year
04

Clear potential to apply the technology
05

Team intending and willing to 'spin-out' in the near future